Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer
- 21 Downloads
We have previously reported the effect of a differentiation inducer, sodium butyrate (SB), on human hepatocellular carcinoma (HCC) cell lines, demonstrating that it was a potent inducer of differentiation. In the present study, we investigated the alteration in expression of an antigen defined by a murine monoclonal antibody, H2, as well as alterations in the expression of other antigens, on the HCC cell lines HCC-T, HCC-M, and PLC/PRF/5, since it is known that specific antigenic changes occur during the differentiation of leukemic cells. The expression of the antigen defined by H2 increased immunocytochemically on HCC-T, HCC-M, and PLC/PRF/5 during treatment with SB. A flowcytometric study showed that almost all the HCC-T and HCC-M cells treated with SB highly expressed this antigen after 5 days' treatment. The antigen expression detected by H2 decreased after the removal of SB from the medium. On the other hand, antigen expression detected by another monoclonal antibody, 5C11, was not changed by this treatment. The expression of intracellular adhesion molecule (ICAM)-1 in HCC-T increased slightly, but that of β2-microglobulin and HLA-DR did not change. These results demonstrated that some antigen expression was changed by SB treatment and that the antigen defined by H2 seemed to be highly expressed on human HCC cells in the differentiated state.
Key wordshepatocellular carcinoma differentiation sodium butyrate monoclonal antibody liver-specific antigen
Unable to display preview. Download preview PDF.
- 1.Mullins TD, Kern HF, Metzgar RS. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines. Pancreas 1992;6:578–587.Google Scholar
- 4.Saito H, Morizane T, Watanabe T, et al. Study of oncogene expression and its changes induced by sodium butyrate in human hepatoma cell lines. Gastroenterology 1990;98:A626.Google Scholar
- 11.Morizane T, Tsuchimoto K, Iino A, et al. Two different murine monoclonal antibodies, B2 and H2, which are specific for human hepatocytes (in Japanese with English abstract). Kanzou (Acta Hepatol Jap) 1986;27:726–735.Google Scholar
- 12.MacFarlane IG, Wojcicka BM, Zucker GM, et al. Purnication and characterization of human liver-specific lipoprotein (LSP). Clin Exp Immunol 1977;27:381–390.Google Scholar
- 13.Iino A. Expression of a human liver-specific antigen defined by the murine monoclonal antibody H2 in various cells (in Japanese with English abstract). Keio Igaku (J Kero Med Soc) 1986; 63:533–543.Google Scholar
- 18.Nojiri H, Takaku F, Ohta M, et al. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of promyelocytic leukemia cell line HL-60. Cancer Res 1985;45:6100–6106.PubMedGoogle Scholar
- 20.Nojiri H, Kitagawa S, Nakamura M, et al. Neolacto-series gangliosides induce granulocytic differentiation of human promyelocytic leukemia cell line HL-60. Biol Chem 1988;263:7443–7446.Google Scholar
- 23.Nakamura M, Tsunoda A, Sakoe K, et al. Total metabolic flow of glycosphingolipid biosynthesis is regulated by UDP-GlcNAc: lactosylceramide β1-3N-acetylglucosaminyltransferase and CMP-NeuAc: lactosylceramide α2–3 sialyl-trasferase in human hematopoietic cell line HL-60 during differentiation. J Biol Chem 1992;267:23507–23514.PubMedGoogle Scholar